STIs Overview: Managing Chlamydia, Gonorrhea, and Syphilis Today

Every year, millions of people get infected with chlamydia, gonorrhea, or syphilis. These aren’t rare or distant threats-they’re common, treatable, and often silent. In 2021, the U.S. reported over 2.5 million cases of just these three bacterial STIs. Half of them were in people between 15 and 24. And here’s the real problem: most of those infected don’t even know it.

Why These Three STIs Matter

Chlamydia, gonorrhea, and syphilis are caused by different bacteria, but they share one dangerous trait: they can spread without symptoms. You can have chlamydia for months without noticing anything-no pain, no discharge, no burning. The same goes for gonorrhea. And syphilis? It can hide in plain sight, mimicking allergies, rashes, or even the flu.

That’s why these infections are called silent epidemics. The World Health Organization estimates 129 million new chlamydia cases, 82 million gonorrhea cases, and 7.1 million syphilis cases globally each year. In the U.S., Black Americans face rates 5 to 7 times higher than White Americans. This isn’t just about biology-it’s about access to care, stigma, and systemic gaps in testing.

Untreated, these infections don’t just disappear. They cause damage. Chlamydia can lead to pelvic inflammatory disease (PID), which scars the fallopian tubes and causes infertility in up to 20% of women. Gonorrhea can spread to the bloodstream, triggering life-threatening joint infections. Syphilis, if ignored for years, can attack the heart, brain, and nerves.

How They Spread-and How to Stop It

These STIs spread through unprotected vaginal, anal, or oral sex. They can also pass from mother to baby during childbirth. That’s why prenatal screening is now mandatory in most U.S. states. A pregnant woman with untreated syphilis has a 40% chance of passing it to her baby-leading to stillbirth, premature birth, or severe birth defects.

Condoms reduce transmission significantly: 60-90% for chlamydia and gonorrhea, and 50-70% for syphilis. But they aren’t foolproof. Skin-to-skin contact during oral sex can still spread syphilis sores or gonorrhea in the throat. That’s why testing isn’t just about genitals-it’s about the mouth, rectum, and throat too.

Diagnosis: What Tests Actually Tell You

Testing is simple, fast, and often free at clinics. But the method changes depending on the infection.

• Chlamydia and gonorrhea: A urine sample or swab from the cervix, urethra, rectum, or throat. These tests detect bacterial DNA. They’re accurate, non-invasive, and results come back in 1-3 days.
• Syphilis: Requires a blood test. It looks for antibodies your body makes in response to the bacteria. There are two types: non-treponemal (like RPR) for screening, and treponemal (like TP-PA) to confirm. A positive blood test doesn’t mean you’re still infected-it could mean you had it years ago and were treated.

Important: If you’ve had unprotected sex with someone who tested positive, get tested-even if you feel fine. And if you’re under 25 and sexually active, get tested at least once a year. If you have multiple partners or use PrEP, test every 3-6 months.

Treatment: What Works, What Doesn’t

Here’s the good news: all three are curable with antibiotics. The bad news? The rules keep changing.

Chlamydia

The first-line treatment is doxycycline: 100 mg twice a day for 7 days. It’s cheap, effective, and kills the infection in over 95% of cases. Azithromycin (a single 1-gram pill) is an alternative, especially if someone can’t take doxycycline.

But here’s the catch: if you take the medicine but your partner doesn’t, you’ll get reinfected. Studies show 14-20% of young women get chlamydia again within a year-not because the treatment failed, but because their partner was still infected.

Gonorrhea

This one’s trickier. Gonorrhea used to be easy to treat with oral pills. Now? It’s resistant to almost everything.

The CDC’s current guideline: one shot of ceftriaxone (500 mg) into the muscle, plus one pill of azithromycin (1 g). But even this combo is failing in some places. In parts of Europe and Australia, up to half of gonorrhea strains are now resistant to azithromycin. That’s why doctors now test throat infections separately-treatment failure rates there are higher.

There’s hope on the horizon. A new drug called zoliflodacin showed 96% cure rates in late-stage trials and could be approved by 2025. Until then, we’re stuck with this last-line defense.

Syphilis

Syphilis treatment depends on how long you’ve had it.

• Early syphilis (less than 1 year): One shot of benzathine penicillin G (2.4 million units). That’s it.
• Late syphilis (more than 1 year, or unknown): Three shots, one per week.
• Neurosyphilis (infection in the brain): Daily IV penicillin for 10-14 days.

If you’re allergic to penicillin, alternatives exist-but they’re less reliable. That’s why doctors still recommend penicillin as the gold standard.

What Happens After Treatment?

Getting treated doesn’t mean you’re done. You need to follow up.

• Retest in 3 months for chlamydia and gonorrhea. Reinfection is common, especially in young people.
• For syphilis, your doctor will order blood tests at 6, 12, and 24 months to make sure the antibodies are dropping. If they’re not, you might need another round of treatment.
• Test-of-cure is required for pharyngeal gonorrhea. A simple swab 2 weeks after treatment confirms it’s gone.

And don’t forget: tell your partners. The CDC recommends treating anyone you had sex with in the past 60 days for chlamydia or gonorrhea, and up to 90 days for syphilis. Health departments can help do this anonymously if you’re uncomfortable.

The New Tool: DoxyPEP

There’s a game-changer that’s flying under the radar: doxycycline after sex, or DoxyPEP.

Three clinical trials showed that taking a single 200-mg pill of doxycycline within 72 hours after condomless sex cut chlamydia, gonorrhea, and syphilis rates by 47-73% in men who have sex with men and transgender women on PrEP. It’s not a magic bullet-it doesn’t work for cisgender women, and it doesn’t prevent HIV. But for high-risk groups, it’s a powerful shield.

The CDC only recommends it for MSM and transgender women right now. Why? Because we don’t have enough data for other groups. And there’s concern about antibiotic resistance. But for those who qualify, it’s one of the most effective prevention tools we have.

Why This Isn’t Just a Medical Problem

STIs don’t spread because people are careless. They spread because testing is hard to access, condoms aren’t always available, and stigma keeps people silent.

Black Americans are 5-7 times more likely to get chlamydia or gonorrhea-not because of behavior, but because of systemic issues: fewer clinics in their neighborhoods, longer wait times, fear of judgment, and lack of culturally competent care.

The cost of untreated STIs? Over $16 billion a year in the U.S. alone. That’s billions spent on fertility treatments, hospitalizations, and emergency care that could’ve been avoided with simple testing and early treatment.

What You Can Do

• Get tested regularly-even if you feel fine.
• Use condoms consistently, but don’t assume they’re 100%.
• Tell your partners if you test positive. They need to get treated too.
• If you’re on PrEP, ask your provider about DoxyPEP.
• Know the signs: unusual discharge, burning when you pee, rashes, sores, or swollen glands.

STIs are not a moral failure. They’re a public health issue. And we have the tools to stop them. But only if we use them.